Upstaging of non-Hodgkin's lymphoma in a child based on 67Gallium scintigraphy

Journal of Pediatric Hematology/oncology
J B ParkhurstJ C Leonard

Abstract

To describe a patient whose non-Hodgkin's lymphoma (NHL) appeared to be localized by standard modalities but who was upstaged after Gallium scintigraphy suggested disseminated disease. A patient with biopsy proven NHL in the maxillary sinus was staged as having localized disease based on computed tomography (CT) scans, bone scintigraphy, and evaluation of bone marrow and spinal fluid. Open biopsy of a bony lesion, standard modalities for lymphoma staging, and Gallium scintigraphy were obtained. Gallium scanning showed bony lesions not previously seen with the standard modalities. Open biopsy of one of these lesions confirmed disseminated disease. Gallium scanning aids in the early identification of metastases in some patients with NHL and should be included in a standard evaluation of apparently localized disease.

References

Jul 1, 1978·Seminars in Nuclear Medicine·D A TurnerR E Slayton
Dec 1, 1975·Radiology·S D RichmanJ L Ziegler
Jan 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A T MeadowsC J Stolar
Jul 1, 1987·Radiology·S S TumehB L Holman
Oct 1, 1985·AJR. American Journal of Roentgenology·R B GlassA Shkolnik
May 1, 1980·The American Journal of Medicine·D L LongoR C Young
Aug 1, 1983·The American Journal of Medicine·K C AndersonW D Kaplan
Jan 1, 1995·Seminars in Nuclear Medicine·D Front, O Israel

❮ Previous
Next ❯

Citations

Dec 3, 1999·British Journal of Haematology·C R Pinkerton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.